Bottom line
FHLC vs VGHCX: the short answer
FHLC (Fidelity MSCI Health Care Index ETF) and VGHCX (Vanguard Health Care Fund) share a meaningful slice of their top holdings — about 53% by weight.
But FHLC is far broader, holding 337 positions to 97 for VGHCX, so beyond the top names it adds exposure VGHCX doesn't have.
FHLC is cheaper at 0.084% vs 0.33% — a difference of $25 a year per $10,000 invested.
Over five years, FHLC returned +7.2% a year vs +6.6% for VGHCX (reporting dates differ).
Updated Nov 19, 2026
FHLC vs VGHCX side by side
| FHLC | VGHCX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Fidelity | Vanguard |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.084% | 0.33% |
| Annual cost per $10k | $8.4 | $33 |
| 10-yr cost on $10k (prospectus) | $108 | $418 |
| Max front load | None | 0% |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +2.6% | +17.3% |
| 5-yr return (annualized) | +7.2% | +6.6% |
| 10-yr return (annualized) | +8.8% | +7.7% |
| Best quarter | +16.4% | +16.8% |
| Worst quarter | −13.1% | −12.3% |
| Net assets (fund) | $3.3B | $38.2B |
| Number of holdings | 337 | 97 |
| Portfolio turnover | 3% | 47% |
| Returns as of | Nov 30, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | FHLC | VGHCX | Difference |
|---|---|---|---|
| 2024 | +2.6% | −1.6% | +4.2% |
| 2023 | +2.5% | +5.4% | −3.0% |
| 2022 | −5.5% | −1.1% | −4.4% |
| 2021 | +20.4% | +14.3% | +6.1% |
| 2020 | +18.1% | +12.6% | +5.5% |
| 2019 | +21.9% | +22.9% | −1.0% |
| 2018 | +5.5% | +1.2% | +4.4% |
Source: Fund prospectus bar charts
Holdings overlap
14 of FHLC's top 25 holdings also appear in VGHCX's top 25.
| Holding | FHLC | VGHCX |
|---|---|---|
| Eli Lilly & Co | 13.35% | 8.61% |
| Johnson & Johnson | 8.93% | 4.83% |
| AbbVie Inc | 6.42% | 2.30% |
| UnitedHealth Group Inc | 5.44% | 4.05% |
| Merck & Co Inc | 4.66% | 5.44% |
| CVS Health Corp | 1.92% | 2.52% |
| Intuitive Surgical Inc | 1.82% | 2.52% |
| Danaher Corp | 1.80% | 2.18% |
| Vertex Pharmaceuticals Inc | 1.76% | 2.36% |
| Elevance Health Inc | 1.19% | 1.83% |
| Regeneron Pharmaceuticals Inc | 1.15% | 2.14% |
| Boston Scientific Corp | 1.00% | 1.53% |
| HCA Healthcare Inc | 0.91% | 1.68% |
| Cencora Inc | 0.83% | 2.47% |
Source: SEC Form N-PORT
FHLC top 10
- Eli Lilly & Co — 13.35%
- Johnson & Johnson — 8.93%
- AbbVie Inc — 6.42%
- UnitedHealth Group Inc — 5.44%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 3.09%
- Amgen Inc — 3.00%
- Abbott Laboratories — 2.66%
- Gilead Sciences Inc — 2.34%
- Pfizer Inc — 2.06%
VGHCX top 10
- Eli Lilly & Co — 8.61%
- Merck & Co Inc — 5.44%
- Johnson & Johnson — 4.83%
- AstraZeneca PLC — 4.59%
- UnitedHealth Group Inc — 4.05%
- Gsk Plc — 3.00%
- Edwards Lifesciences Corp — 2.56%
- Intuitive Surgical Inc — 2.52%
- CVS Health Corp — 2.52%
- Cencora Inc — 2.47%
FAQ
What is the difference between FHLC and VGHCX?
Which is cheaper, FHLC or VGHCX?
Should I own both FHLC and VGHCX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.